Market Cap
$25.41B$7.98M-0.03%
Summary
- Current Value
- As of today, MRNA market cap is $25B, down -0.03% in the most recent trading session on
- Category
- Based on its current market cap, MRNA falls into the Large Cap category
- Historical Performance
- MRNA market cap is up +118.70% year-to-date, up +142.93% over the past 365 days
- All-Time High Comparison
- MRNA market cap is currently -86.98% below its historical high of $195B set on
- 3-Year Low Comparison
- MRNA market cap is +190.66% above its 3-year low of $9B reached on
- Sector Comparison
- MRNA market cap is higher than 94.49% of companies in Healthcare sector
Market Cap Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $25B | -0.0% | -4.4% | +27.0% | +118.7% | +142.9% | -34.3% | -83.8% | |
| Price | $63.65 | -0.0% | -5.0% | +26.2% | +115.8% | +136.7% | -37.3% | -83.7% | |
| Shares Outstanding | 399.24M | +0.6% | – | – | – | +2.6% | +4.8% | -0.9% | |
| PE Ratio | - | – | – | – | – | – | – | – | |
| TTM Revenue | $2.23B | +0.1% | – | +0.1% | – | -27.6% | -78.9% | -68.3% | |
| TTM EPS | -$7.98 | +2.0% | – | +2.0% | – | -6.2% | -393.3% | -199.7% | |
| $21.56B | -0.0% | -5.2% | +33.9% | +202.6% | +255.2% | -31.3% | -85.6% | ||
| TTM Dividend | - | – | – | – | – | – | – | – | |
| TTM Net Income | -$3.15B | +1.4% | – | +1.4% | – | -8.5% | -361.1% | -190.2% |
Market Cap Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | $27B | -6.2% | |
| 3M | $32B | -21.7% | |
| 6M | $32B | -21.7% | |
| 1Y | $32B | -21.7% | |
| 3Y | $64B | -60.2% | |
| 5Y | $184B | -86.2% | |
| All | $195B | -87.0% |
Market Cap Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | $21B | +18.4% | |
| 3M | $18B | +40.3% | |
| 6M | $17B | +54.0% | |
| 1Y | $9B | +190.7% | |
| 3Y | $9B | +190.7% | |
| 5Y | $9B | +190.7% | |
| All | $4B | +528.2% |
Market Cap History
| Date | Value | Change |
|---|---|---|
| $25B | +118.7% | |
| $12B | -27.6% | |
| $16B | -57.8% | |
| $38B | -45.1% | |
| $69B | -32.4% |
| Date | Value | Change |
|---|---|---|
| $102B | +145.7% | |
| $42B | +532.9% | |
| $7B | +31.1% | |
| $5B | - |
FAQ
- What is the current market cap of MRNA?
- As of today, MRNA market cap is $25B
- What market cap category does MRNA fall into?
- Based on its current market cap, MRNA falls into the Large Cap category
- What is MRNA market cap today change?
- MRNA market cap is down -0.03% today
- What is 1-year change in MRNA market cap?
- MRNA market cap is up +142.93% year-over-year
- How far is MRNA market cap from its all-time high?
- MRNA market cap is currently -86.98% below its historical high of $195B set on August 9, 2021
- How does MRNA market cap rank versus sector peers?
- MRNA market cap is higher than 94.49% of companies in Healthcare sector
Market Cap Formula
Market Cap = Price × Shares Outstanding
Data Sources & References
- MRNA Official Website www.modernatx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1682852/000162828025053816/0001628280-25-053816-index.htm
- MRNA Profile on Yahoo Finance finance.yahoo.com/quote/MRNA
- MRNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrna